Ahmed E Nasser, Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 |
Dr. Matthew R. Kaufman, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 Fax: 732-747-2606 |
Dr. Mark Yazid, M.D Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 |
Lisa Frances Schneider, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 Fax: 732-747-2606 |
Dr. Tushar R. Patel, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 Fax: 732-747-2606 |
Dr. Michael I Rose, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 Fax: 732-747-2606 |
Dr. Jonathan M Weiswasser, MD Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 |
Dr. Eric Geoffrey Wimmers, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 |
Cristina Doran, Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 917-622-9334 |
Dr. Andrew I Elkwood, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 Fax: 732-747-2606 |
Dr. James Steven Brock, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 Shrewsbury Ave, Suite 210, Shrewsbury, NJ 07702 Phone: 732-747-4744 Fax: 732-747-4751 |
Justyna M Cerefin, PA-C Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 |
Dr. Camille Swain, D.O. Surgery - Surgical Oncology Medicare: Medicare Enrolled Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 |
Zuhaib Ibrahim, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 717-608-2250 |
Dr. Russell Lee Ashinoff, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 Fax: 732-747-2606 |
Dr. Eric I-yun Chang, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 Fax: 732-747-2606 |
Chrisovalantis Lakhiani, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-741-0970 Fax: 732-747-2606 |
Dr. Adam Saad, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 535 Sycamore Ave, Shrewsbury, NJ 07702 Phone: 732-426-3420 |
Dr. Joseph Elmo Cauda, MD FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 Shrewsbury Ave, Suite 210, Shrewsbury, NJ 07702 Phone: 732-747-4744 Fax: 732-747-4751 |
News Archive
Fecal immunochemical tests could allow noninvasive assessment of patients with ulcerative colitis, say the authors of a Japanese study.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Normally, tissue injury triggers a mechanism in cells that tries to repair damaged tissue and restore the skin to a normal, or homeostatic state. Errors in this process can give rise to various problems, such as chronic inflammation, which is a known cause of certain cancers.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
› Verified 7 days ago